ADAPTIVE BIOTECHNOLOGIES CORP
NASDAQ: ADPT (Adaptive Biotechnologies Corpor)
Kemas kini terakhir: 2 hari lalu, 11:16PM24.74
0.28 (1.14%)
| Penutupan Terdahulu | 24.46 |
| Buka | 24.27 |
| Jumlah Dagangan | 1,743,224 |
| Purata Dagangan (3B) | 2,950,883 |
| Modal Pasaran | 3,935,134,976 |
| Harga / Jualan (P/S) | 12.83 |
| Harga / Buku (P/B) | 28.34 |
| Julat 52 Minggu |
| Margin Keuntungan | -74.84% |
| Margin Operasi (TTM) | -56.45% |
| EPS Cair (TTM) | -0.950 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 25.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 115.90% |
| Nisbah Semasa (MRQ) | 2.92 |
| Aliran Tunai Operasi (OCF TTM) | -85.34 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -21.40 M |
| Pulangan Atas Aset (ROA TTM) | -15.05% |
| Pulangan Atas Ekuiti (ROE TTM) | -61.03% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Adaptive Biotechnologies Corpor | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.00 |
|
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 2.35% |
| % Dimiliki oleh Institusi | 98.36% |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BOBULSKY SUSAN | - | 25.45 | -3,000 | -76,350 |
| Jumlah Keseluruhan Kuantiti Bersih | -3,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -76,350 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 25.45 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| BOBULSKY SUSAN | Pegawai | 10 Aug 2026 | Jual automatik (-) | 3,000 | 25.45 | 76,350 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |